The funds allocated by the state for the treatment of patients with acute lymphoblastic leukemia should be increased if necessary. This opinion was expressed by the chief pediatric oncologist-hematologist, member of the Presidium of the Russian Academy of Sciences, founder of the Rogachev Center Alexander Rumyantsev.
He noted that now about 100 thousand rubles are allocated for the treatment of the most common tumor in children per patient, which does not always allow the use of the most effective medicines and equipment. According to him, the cost of fighting this disease can reach 1.5 million rubles.
Rumyantsev explained that often the necessary expensive drugs are excluded from the list of drugs on the basis of the fact that their instructions do not prescribe indications for children.
In this regard, the doctor called for changes in the legislation to conduct treatment based on clinical recommendations developed by the professional community, as well as to provide real funding for the successful treatment of patients.
Treatment of acute lymphoblastic leukemia in the Russian Federation is based on the Moscow-Berlin protocol developed by the D. Rogachev Center. According to experts, its use has allowed to bring the number of people cured in the capital to 91.3% and to 82% in the whole country.
Earlier, Rumyantsev expressed the opinion that the online sale of medicines will be useful for many groups of the population.